Skip to main content
NCBI home page
Clinical Cardiology logoLink to Clinical Cardiology
. 2009 Feb 3;23(9):645–652. doi: 10.1002/clc.4960230904

Endothelial dysfunction, subangiographic atheroma, and unstable symptoms in patients with chest pain and normal coronary arteriograms

Jonathan R Clague 1, Jens‐Peder Bagger 2, David E Ward 3, Ian D Cox 3,†, Juan‐Carlos Kaski 3,✉
PMCID: PMC6654817  PMID: 11016013

Abstract

Background: Patients with chest pain and normal coronary arteriograms (CPNA) may present with unstable symptoms and other evidence of ischemia during clinical follow‐up. Although repeat angiography usually proves negative, functional assessment of coronary vasomotor abnormalities may provide additional pathophysiologic information.

Hypothesis: The study was undertaken to evaluate the relationship between endothelial dysfunction and subangiographic atheroma in patients with CPNA undergoing repeat angiography because of unstable symptoms.

Methods: We investigated nine patients with CPNA (8 women, mean age 57 ± 9 years) undergoing repeat angiography because of unstable anginal symptoms. After normal angiography, simultaneous coronary epicardial and microvascular vasomotor responses to intracoronary vasodilators [acetylcholine (10−6 M), adenosine (18 μg) and nitroglycerin (300 μg)] were investigated in the left anterior descending artery using quantitative angiography and Doppler flow measurements. The presence of subangiographic atheroma was assessed by intravascular ultrasound.

Results: Three patients demonstrated proximal and distal epicardial vasoconstriction and a reduction in coronary flow in response to acetylcholine, indicating concordant epicardial and microvascular endothelial dysfunction. These changes were associated with chest pain and ischemic electrocardio‐graphic changes in two patients. None of the remaining patients suffered chest pain in response to intracoronary acetylcholine. Six patients had significant subangiographic disease (intimal thickness >0.3 mm) on intravascular ultrasound imaging, and multivariate analysis indicated a significant relationship (R2 = 0.89, overall p = 0.001) between the extent of subangiographic disease and both plasma cholesterol concentration and hypertensive history. No significant relationship was demonstrated between endothelial dysfunction and the extent of subangiographic disease.

Conclusion: Concordant epicardial and microvascular endothelial dysfunction may be pathophysiologically and clinically significant in unstable patients with CPNA but does not appear to be directly related to the extent of subangiographic atheroma.

Keywords: chest pain, normal coronary arteriogram, endothelial dysfunction, subangiographic atheroma

Full Text

The Full Text of this article is available as a PDF (907.4 KB).

References

  • 1. Voelker W, Euchner U, Dittman H, Karsch KR: Long‐term clinical course of patients with angina and angiographically normal coronary arteries. Clin Cardiol 1991; 14: 307–311 [DOI] [PubMed] [Google Scholar]
  • 2. Kaski JC, Rosano GM, Collins P, Nihoyannopoulos P, Maseri A, Poole‐Wilson P: Cardiac syndrome X: Clinical characteristics and left ventricular function. A long‐term follow‐up study. J Am Coll Cardiol 1995; 25: 807–814 [DOI] [PubMed] [Google Scholar]
  • 3. Cox ID, Schwartzman R, Atienza F, Brown SJ, Kaski JC: Angiographic disease progression in patients with angina pectoris and normal coronary angiograms who are restudied due to unstable symptoms. Eur Heart J 1998; 19: 1027–1033 [DOI] [PubMed] [Google Scholar]
  • 4. Haft J, Bachik M: Progression of coronary artery disease in patients with chest pain and normal or intraluminal disease on arteriography. Am J Cardiol 1984; 107: 35–39 [DOI] [PubMed] [Google Scholar]
  • 5. Cannon R, Epstein S: “Microvascular angina” as a cause of chest pain with angiographically normal coronary arteries. Am J Cardiol 1988; 61: 1338–1343 [DOI] [PubMed] [Google Scholar]
  • 6. Mohri M, Koyanagi M, Egashira K, Tagawa H, Ichiki T, Shimokawa H, Takeshita A: Angina pectoris caused by coronary microvascular spasm. Lancet 1998; 351: 1165–1169 [DOI] [PubMed] [Google Scholar]
  • 7. Vrints C, Bult H, Hitter E, Herman A, Snoeck J: Impaired endothelium dependent cholinergic vasodilation in patients with angina and normal coronary angiograms. J Am Coll Cardiol 1992; 19: 21–31 [DOI] [PubMed] [Google Scholar]
  • 8. Motz W, Vogt M, Rabenau O, Scheler S, Luckhoff A, Strauer BE: Evidence of endothelial dysfunction in coronary resistance vessels in patients with angina pectoris and normal coronary angiograms. Am J Cardiol 1991; 68: 996–1003 [DOI] [PubMed] [Google Scholar]
  • 9. Quyyumi AA, Cannon RO, Panza JA, Diodati JG, Epstein SE: Endothelial dysfunction in patients with chest pain and normal coronary arteries. Circulation 1992; 86: 1864–1871 [DOI] [PubMed] [Google Scholar]
  • 10. Egashira K, Inou T, Hirooka Y, Yamada A, Urabe Y, Takeshita A: Evidence of impaired endothelium‐dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms. N Engl J Med 1993; 328: 1659–1664 [DOI] [PubMed] [Google Scholar]
  • 11. Zeiher AM, Krause T, Schachinger V, Minners J, Moser E: Impaired endothelium‐dependent vasodilation of the coronary resistance vessels is associated with exercise induced myocardial ischemia. Circulation 1995; 91: 2345–2352 [DOI] [PubMed] [Google Scholar]
  • 12. Hasdai D, Gibbons RI, Holmes DR, Higano ST, Lerman A: Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. Circulation 1997; 96: 3390–3395 [DOI] [PubMed] [Google Scholar]
  • 13. Wiedemann O, Schwartz A, Apfelbaum M: Anatomic and physiologic heterogeneity in patients with syndrome X. J Am Coll Cardiol 1995; 25: 1310–1317 [DOI] [PubMed] [Google Scholar]
  • 14. Braunwald E: Unstable angina. A classification. Circulation 1989; 80: 410–414 [DOI] [PubMed] [Google Scholar]
  • 15. Takata J, Couniham PJ, Gane J, Doi Y, Chikamori T, Owaza T, McKenna WJ: Regional thallium‐201 washout in hypertrophic cardiomyopathy and its relation to exertional chest pain. Am J Cardiol 1993; 72: 211–217 [DOI] [PubMed] [Google Scholar]
  • 16. Doucette JW, Corl P, Payne H, Flynn A, Goto M, Nassi M, Segal J: Validation of a Doppler guidewire for intravascular measurement of coronary artery flow velocity. Circulation 1992; 85: 1899–1911 [DOI] [PubMed] [Google Scholar]
  • 17. Furghott RF: Role ofendothelium in responses of vascular smooth muscle. Circ Res 1983; 53: 557–573 [DOI] [PubMed] [Google Scholar]
  • 18. Reddy KG, Nair RN, Sheehan HM, Hodgson JM: Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis. J Am Coll Cardiol 1994; 23: 833–843 [DOI] [PubMed] [Google Scholar]
  • 19. Hori M, Kitakaze M: Adenosine, the heart and coronary circulation. Hypertension 1991; 18: 565–574 [DOI] [PubMed] [Google Scholar]
  • 20. Wilson RF, Wyche K, Christensen BV, Laxson DD: Effects of adenosine on human coronary arterial circulation. Circulation 1990; 82; 1595–1606 [DOI] [PubMed] [Google Scholar]
  • 21. Harrison DG, Bates JN: The nitrosovasodilators: New ideas about old drugs. Circulation 1993; 87: 1461–1467 [DOI] [PubMed] [Google Scholar]
  • 22. Nishimura RA, Lerman A, Chesebro JH, Ilstrup DM, Hodge DO, Higano ST, Holmes DR, Tajik J: Epicardial vasomotor responses to acetylcholine are not predicted by coronary atherosclerosis as assessed by intracoronary ultrasound. J Am Coll Cardiol 1995; 26: 41–49 [DOI] [PubMed] [Google Scholar]
  • 23. Reiber JHC, Serruys PW, Kooijman CJ, Wijns W, Slager CJ, Gerbrands JJ, Schuurbiers JC, den Boer A, Hugenholtz PG: Assessment of short‐, medium‐ and long‐term variations in arterial dimensions from a computer assisted quantitation of coronary cineangiograms. Circulation 1985; 71: 280–288 [DOI] [PubMed] [Google Scholar]
  • 24. Nissen SE, Gurley JC, Booth DC, DeMaria AN: Intravascular ultrasound of the coronary arteries: Current applications and future directions. Am J Cardiol 1992; 69: 18H–29H [DOI] [PubMed] [Google Scholar]
  • 25. Gould KL, Lipscomb K: Effects of coronary stenoses on coronary flow reserve and resistance. Am J Cardiol 1974; 34: 48–55 [DOI] [PubMed] [Google Scholar]
  • 26. Kessler KM. Syndrome X: The epicardial view. J Am Coll Cardiol 1992; 19: 32–33 [DOI] [PubMed] [Google Scholar]
  • 27. Eitamimi H, Mansour M, Wargovich TJ, Hill JA, Kerensky RA, Conti R, Pepine CJ: Constrictor and dilator responses to intracoronary acetylcholine in adjacent segments of the same coronary artery in patients with coronary artery disease. Circulation 1994; 89: 45–51 [DOI] [PubMed] [Google Scholar]
  • 28. Tousoulis D, Davies G, Lefroy DC, Haider AW, Crake T: Variable coronary vasomotor responses to acetylcholine in patients with normal coronary angiograms: Evidence for localised endothelial dysfunction. Heart 1996; 75: 261–266 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W, Rosenfeld ME, Schaffer SA, Schwartz CJ, Wagner WD, Wissler RW: A definition of initial, fatty streak and intermediate lesions of atherosclerosis. Circulation 1994; 89: 2462–2478 [DOI] [PubMed] [Google Scholar]
  • 30. Erbel R, Ge J, Bockisch A, Kearney P, Gorge G, Haude M, Schumann D, Zamorano J, Rupprecht HJ, Meyer J: Value of intracoronary ultrasound and Doppler in the differentiation of angiographically normal coronary arteries: A prospective study in patients with angina pectoris. Eur Heart J 1996; 17: 880–889 [DOI] [PubMed] [Google Scholar]
  • 31. Vita JA, Treasure CB, Nabel EG, McLenachan JM, Fish D, Yeung AC, Vekshtein VI, Selwyn AR Ganz P: Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 1990; 81: 491–497 [DOI] [PubMed] [Google Scholar]
  • 32. Zeiher A, Drexler H, Saurbier B, Just H: Modulation of coronary vasomotor tone in humans: Progressive endothelial dysfunction with different early stages of atherosclerosis. Circulation 1991; 83: 391–401 [DOI] [PubMed] [Google Scholar]
  • 33. Schweninger V, Zeiher AM: Alterations of coronary blood flow and myocardial perfusion in hypercholesterolaemia. Heart 1996; 76: 295–298 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Miller DD, Donohue TJ, Younis LT, Bach RG, Aguirre FV, Wittry MD, Goodgold HM, Chaitman BR, Kern MJ: Correlation of pharmacological 99m Tc‐sestamibi myocardial perfusion imaging with poststenotic coronary flow reserve in patients with angiographically intermediate coronary artery stenoses. Circulation 1994; 89: 2150–2160 [DOI] [PubMed] [Google Scholar]
  • 35. Nittenberg A, Anthony I: Coronary vascular reserve in humans: A critical review of methods of evaluation and of interpretation of the results. Eur Heart J 1995; 16 (suppl I): 7–21 [DOI] [PubMed] [Google Scholar]
  • 36. Chauhan A, Mullins PA, Petch MC, Schofield PM: Is coronary flow reserve in response to papaverine really normal in syndromeX? Circulation 1994; 89: 1998–2004 [DOI] [PubMed] [Google Scholar]
  • 37. Galassi AR, Crea F, Araujo LI, Lammertsma AA, Pupita G, Yamamoto Y, Rechavia E, Jones T, Kaski JC, Maseri A: Comparison of regional myocardial blood flow in syndrome X and one vessel coronary artery disease. Am J Cardiol 1993; 72: 134–139 [DOI] [PubMed] [Google Scholar]
  • 38. Koglin J, von Scheidt W: Isolated defect of adenosine‐mediated coronary vasodilation: Functional evidence for a new microangiopathic entity. J Am Coll Cardiol 1997; 30: 103–107 [DOI] [PubMed] [Google Scholar]
  • 39. Inobe Y, Kugiyama K, Morita E, Kawano H, Okumura K, Tomiguchi S, Tsuji A, Kojima A, Takahashi M, Yasue H: Role of adenosine in the pathogenesis of syndrome X: Assessment with coronary haemodynamic measurements and thallium‐201 myocardial single‐photon emission computed tomography. J Am Coll Cardiol 1996; 28: 890–896 [DOI] [PubMed] [Google Scholar]
  • 40. Buffon A, Conti E, Finnochiaro ML, Beltrame JF, Cianflone D, Crea F, Maseri A: Paradoxical effect of intracoronary nitrates on coronary blood flow in patients with syndrome X (abstr). Eur Heart J 1997; 18 (suppl): 169 [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES